Last reviewed · How we verify
The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
This study aims to investigate the prognostic value of circulating plasma cells (CPCs) in patients with multiple myeloma and explore whether CPCs detection might be used in place of bone marrow aspiration for disease monitoring.
Details
| Lead sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
|---|---|
| Status | RECRUITING |
| Enrolment | 458 |
| Start date | Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Dec 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Multiple Myeloma
Interventions
- Peripheral blood test
Countries
China